Clinical studies and trials have indicated that therapies addressing the PYY system have the potential to reduce food intake, increase satiety, and promote weight loss
GLP-1 medications generally have a more favorable long-term safety profile, with cardiovascular benefits demonstrated in clinical trials
As a result, they help reduce hunger, delay stomach emptying, improve insulin signaling, and support meaningful weight loss
For DTC companies like Hims & Hers, Ro, and Sesame, which have built lucrative businesses selling compounded GLP-1s at lower prices (often $200-$300 per month versus $1,000+ for branded versions), this is major blow
It remains under active clinical evaluation for weight loss and metabolic disorders
Upon selenium supplementation, there is a preferential accumulation of selenium in the thyroid [137]